Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 01 - 19 tags : Cancer save search
The Worldwide Cancer/Tumor Profiling Industry is Predicted to Reach $31+ Billion by 2030
Published: 2022-01-19 (Crawled : 19:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.46%
H: 1.25%
C: -1.16%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: 1.41%
H: 1.39%
C: -2.3%
HTGM | $0.48 -20.0% -26.08% 0
|
Health Technology
|
| O: 0.0%
H: 3.54%
C: -2.28%
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 1.01%
H: 4.5%
C: -1.13%
cancer
Guardant Health to Present Data Highlighting the Clinical Utility of Its Liquid Biopsy Tests in Gastrointestinal Cancers at ASCO GI Cancers Symposium
Published: 2022-01-19 (Crawled : 15:00) - biospace.com/
GH M | $16.08 -3.54% -3.67% 1.9M
|
Health Services
|
| O: -3.27%
H: 3.07%
C: -1.0%
health symposium gastrointestinal asco test cancer
Natera to Present Latest Signatera™ MRD Data in Colorectal and Pancreatic Cancers at the ASCO GI Symposium 2022, and Host Special Investor Call
Published: 2022-01-19 (Crawled : 14:30) - biospace.com/
NTRA S | $85.275 -2.3% -2.35% 2.5M
|
Health Services
|
| O: 0.77%
H: 7.16%
C: -0.62%
symposium asco test cancer pancreatic
ImmunityBio Nant Cancer Vaccine Shows Promise in Metastatic Pancreatic Cancer
Published: 2022-01-19 (Crawled : 14:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
cancer vaccine pancreatic
ESSA Pharma Announces First Patient Dosed in a Phase 1/2 Clinical Trial of EPI-7386 in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
Published: 2022-01-19 (Crawled : 13:00) - biospace.com/
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -0.27%
H: 0.51%
C: 0.21%
EPIX | $6.57 -2.23% -2.28% 100K
|
Health Technology
|
| O: -5.58%
H: 5.2%
C: -1.65%
epi-7386 prostate cancer trial phase 1 cancer
RenovoRx Announces Presentation at the 2022 SPECTRUM Conference Highlighting its Innovative RenovoTAMP™ Therapy for Targeted Treatment of Cancer
Published: 2022-01-19 (Crawled : 12:30) - renovorx.com
RNXT | $1.23 0.82% 0.81% 20K
|
|
| O: -0.49%
H: 1.47%
C: -2.93%
treatment conference presentation therapy cancer
Pet Cancer Therapeutics Market revenue to cross USD 432 Mn by 2027: Global Market Insights Inc.
Published: 2022-01-19 (Crawled : 09:00) - prnewswire.com
ZTS | News | $146.5 -4.32% 0.0% 6.2M
|
Health Technology
|
| O: 0.43%
H: 1.51%
C: -1.11%
therapeutics cancer market
CStone announces the GEMSTONE-302 study of sugemalimab met the endpoint of overall survival in the first-line treatment of metastatic non-small cell lung cancer patients
Published: 2022-01-19 (Crawled : 01:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -1.32%
H: 1.57%
C: -0.21%
stone-302 treatment ema ces cel lung cancer cancer
HUTCHMED Highlights Fruquintinib Clinical Data to be Presented at the 2022 ASCO Gastrointestinal Cancers Symposium
Published: 2022-01-19 (Crawled : 01:00) - globenewswire.com
HCM | $16.49 0.8% 0.79% 61K
|
Health Technology
|
| O: -0.77%
H: 0.0%
C: 0.0%
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 3.04%
H: 0.0%
C: 0.0%
symposium gastrointestinal asco test cancer